Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1942 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.31 USD | -2.04% | +6.05% | +5.43% | +36.71% | 2.17 B USD | ||
| 1949 |  ADMA ADMA Biologics Inc - Common Stock | 9.72 USD | -1.22% | +2.10% | +15.99% | -44.90% | 2.18 B USD | ||
| 1954 |  VCEL Vericel Corporation - Common Stock | 42.66 USD | -0.05% | -3.05% | -6.20% | +17.36% | 2.18 B USD | ||
| 1961 |  MESO Mesoblast Limited - American Depositary Shares | 16.44 USD | -3.29% | -3.92% | +9.75% | +2.75% | 2.10 B USD | ||
| 1978 |  NBTX Nanobiotix S.A. - ADSs | 39.72 USD | -8.79% | +0.28% | -0.10% | +321.66% | 1.92 B USD | ||
| 1979 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 31.24 USD | -3.25% | +6.01% | +1.07% | +18.07% | 2.04 B USD | ||
| 1985 |  BHVN Biohaven Ltd. Common Shares | 13.74 USD | -0.79% | -4.45% | -6.78% | -18.89% | 2.08 B USD | ||
| 1987 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.75 USD | -1.67% | +1.37% | +7.34% | +62.49% | 2.05 B USD | ||
| 1991 |  XNCR Xencor, Inc. - Common Stock | 27.28 USD | -1.87% | +17.28% | +40.04% | +225.54% | 2.03 B USD | ||
| 2008 |  ZYME Zymeworks Inc. - Common Stock | 27.30 USD | -4.78% | +8.59% | +18.34% | +53.89% | 1.94 B USD | ||
| 2018 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.19 USD | -3.19% | +0.94% | +10.44% | -10.13% | 1.92 B USD | ||
| 2020 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.87 USD | -3.61% | -2.33% | +3.71% | +95.67% | 1.91 B USD | ||
| 2026 |  AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.07 USD | -0.06% | -0.87% | -8.72% | -23.78% | 1.97 B USD | ||
| 2045 |  IMCR Immunocore Holdings plc - American Depositary Shares | 36.04 USD | -2.28% | +5.91% | +2.80% | +7.65% | 1.86 B USD | ||
| 2054 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.30 USD | -5.71% | +6.11% | +8.55% | -34.00% | 1.77 B USD | ||
| 2057 |  SEPN Septerna, Inc. - Common Stock | 40.34 USD | +0.85% | -9.96% | +21.32% | +83.28% | 1.88 B USD | ||
| 2077 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 12.40 USD | -3.43% | +4.20% | +12.01% | -9.62% | 1.74 B USD | ||
| 2098 |  GHRS GH Research PLC - Ordinary Shares | 27.45 USD | -3.11% | -6.41% | -1.47% | +93.86% | 1.70 B USD | ||
| 2099 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.26 USD | -1.98% | -2.28% | -8.68% | +18.45% | 1.72 B USD | ||
| 2103 |  FTRE Fortrea Holdings Inc. - Common Stock | 18.27 USD | -0.65% | +4.70% | -6.36% | +119.06% | 1.74 B USD |
Haberler Biotechnology Stocks
Deutsche Bank, argenx hissesini değerleme nedeniyle Tut’a düşürdü
Monte Rosa Therapeutics hissesi neden düşüyor?
Biomea Fusion hisseleri diyabet çalışması kayıt tamamlanmasıyla yükseldi
Monte Rosa hisseleri faz 2 prostat kanseri çalışması başlarken düştü
H.C. Wainwright, Biomea Fusion hissesi için hedef fiyatı korudu
Crinetics Pharmaceuticals hissesi 84,8 dolarda zirve yaptı
FDA, Capricor’un deramiocel incelemesini 22 Kasım’a uzattı
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |